TEM – tempus ai, inc. - class a (US:NASDAQ)
Stock Stats
News
Tempus AI (TEM) Unveils Cancer Test Kit, Soars 13.9% [Yahoo! Finance]
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026
Tempus AI (TEM) was upgraded by TD Cowen from "hold" to "buy". They now have a $65.00 price target on the stock.
Tempus AI (TEM) is now covered by Jefferies Financial Group Inc.. They set an "underperform" rating and a $35.00 price target on the stock.
Form 144 Tempus AI, Inc. Filed by: Doudna Jennifer A
Form ARS Tempus AI, Inc. For: Dec 31
Form DEFA14A Tempus AI, Inc.
Form DEF 14A Tempus AI, Inc. For: May 21
Form 4 Tempus AI, Inc. For: Mar 26 Filed by: LEFKOFSKY ERIC P
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.